Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Alopecia Areata”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Testing effectiveness (Phase 2)Looking for participantsNCT06104839
What this trial is testing

Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata

Who this might be right for
Alopecia Areata
NEXTGEN Bioscience 73
Large-scale testing (Phase 3)Active Not RecruitingNCT07029711
What this trial is testing

Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

Who this might be right for
Severe Alopecia Areata
Pfizer 208
Not applicableStudy completedNCT07226531
What this trial is testing

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Who this might be right for
Alopecia Areata
Pfizer 300
Early research (Phase 1)Looking for participantsNCT07554222
What this trial is testing

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

Who this might be right for
HealthyActive Non-segmental VitiligoSevere Alopecia Areata
Innovent Biologics (Suzhou) Co. Ltd. 160
Testing effectiveness (Phase 2)Ended earlyNCT05496426
What this trial is testing

KL130008 in Adults With Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 114
Testing effectiveness (Phase 2)Looking for participantsNCT07311564
What this trial is testing

LAD603 in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Almirall, S.A. 136
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Post-approval studies (Phase 4)Study completedNCT01167946
What this trial is testing

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Who this might be right for
Alopecia TotalisAlopecia UniversalisOphiasic Alopecia
King Saud University 42
Not applicableLooking for participantsNCT07152119
What this trial is testing

Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.

Who this might be right for
Severe Alopecia Areata
Pfizer 3,000
Testing effectiveness (Phase 2)UnknownNCT05205070
What this trial is testing

Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata

Who this might be right for
Alopecia Areata
AnaptysBio, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT01950780
What this trial is testing

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

Who this might be right for
Alopecia Areata
Columbia University 12
Testing effectiveness (Phase 2)Study completedNCT06786689
What this trial is testing

To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia Areata(AA)
Sheikh Zayed Medical College 60
Testing effectiveness (Phase 2)Looking for participantsNCT07533006
What this trial is testing

LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

Who this might be right for
Alopecia Areata
Eli Lilly and Company 60
Large-scale testing (Phase 3)Looking for participantsNCT07133308
What this trial is testing

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Sun Pharmaceutical Industries, Inc. 355
Testing effectiveness (Phase 2)Active Not RecruitingNCT06018428
What this trial is testing

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Who this might be right for
Alopecia Areata
Q32 Bio Inc. 75
Large-scale testing (Phase 3)Active Not RecruitingNCT03898479
What this trial is testing

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Sun Pharmaceutical Industries, Inc. 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06562894
What this trial is testing

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

Who this might be right for
Severe Alopecia Areata
CSPC Ouyi Pharmaceutical Co., Ltd. 156
Testing effectiveness (Phase 2)Study completedNCT06340360
What this trial is testing

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Who this might be right for
Alopecia Areata
Nektar Therapeutics 94
Testing effectiveness (Phase 2)Ended earlyNCT01840046
What this trial is testing

Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata

Who this might be right for
Alopecia Areata
Centre Hospitalier Universitaire de Nice 4
Not applicableStudy completedNCT04446429
What this trial is testing

Anti-Androgen Treatment for COVID-19

Who this might be right for
COVID-19SARS-CoV2Androgenetic Alopecia+3 more
Applied Biology, Inc. 268
Next Page